182 related articles for article (PubMed ID: 38142971)
1. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes.
Janz A; Walz K; Cirnu A; Surjanto J; Urlaub D; Leskien M; Kohlhaas M; Nickel A; Brand T; Nose N; Wörsdörfer P; Wagner N; Higuchi T; Maack C; Dudek J; Lorenz K; Klopocki E; Ergün S; Duff HJ; Gerull B
Mol Metab; 2024 Jan; 79():101859. PubMed ID: 38142971
[TBL] [Abstract][Full Text] [Related]
2. Reversible Mitochondrial Fragmentation in iPSC-Derived Cardiomyocytes From Children With DCMA, a Mitochondrial Cardiomyopathy.
Rohani L; Machiraju P; Sabouny R; Meng G; Liu S; Zhao T; Iqbal F; Wang X; Ravandi A; Wu JC; Khan A; Shutt T; Rancourt D; Greenway SC
Can J Cardiol; 2020 Apr; 36(4):554-563. PubMed ID: 32046906
[TBL] [Abstract][Full Text] [Related]
3. Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation.
Janz A; Chen R; Regensburger M; Ueda Y; Rost S; Klopocki E; Günther K; Edenhofer F; Duff HJ; Ergün S; Gerull B
Stem Cell Res; 2020 Jul; 46():101856. PubMed ID: 32521499
[TBL] [Abstract][Full Text] [Related]
4. Investigating
Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
[No Abstract] [Full Text] [Related]
5. Novel homozygous pathogenic mitochondrial DNAJC19 variant in a patient with dilated cardiomyopathy and global developmental delay.
Al Tuwaijri A; Alyafee Y; Alharbi M; Ballow M; Aldrees M; Alam Q; Sleiman RA; Umair M; Alfadhel M
Mol Genet Genomic Med; 2022 Aug; 10(8):e1969. PubMed ID: 35611801
[TBL] [Abstract][Full Text] [Related]
6. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
[TBL] [Abstract][Full Text] [Related]
7. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
[TBL] [Abstract][Full Text] [Related]
8. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition.
Davey KM; Parboosingh JS; McLeod DR; Chan A; Casey R; Ferreira P; Snyder FF; Bridge PJ; Bernier FP
J Med Genet; 2006 May; 43(5):385-93. PubMed ID: 16055927
[TBL] [Abstract][Full Text] [Related]
9. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
10. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
[TBL] [Abstract][Full Text] [Related]
11. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
[TBL] [Abstract][Full Text] [Related]
12. Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction.
Korover N; Etzion S; Cherniak A; Rabinski T; Levitas A; Etzion Y; Ofir R; Parvari R; Cohen S
Biol Res; 2023 Jun; 56(1):34. PubMed ID: 37349842
[TBL] [Abstract][Full Text] [Related]
13. New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies.
Ojala T; Polinati P; Manninen T; Hiippala A; Rajantie J; Karikoski R; Suomalainen A; Tyni T
Pediatr Res; 2012 Oct; 72(4):432-7. PubMed ID: 22797137
[TBL] [Abstract][Full Text] [Related]
14. Phenotype and pathology of the dilated cardiomyopathy with ataxia syndrome in children.
Machiraju P; Degtiarev V; Patel D; Hazari H; Lowry RB; Bedard T; Sinasac D; Brundler MA; Greenway SC; Khan A
J Inherit Metab Dis; 2022 Mar; 45(2):366-376. PubMed ID: 34580891
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
16. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
17. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
18. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
[TBL] [Abstract][Full Text] [Related]
20. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients.
Willi L; Abramovich I; Fernandez-Garcia J; Agranovich B; Shulman M; Milman H; Baskin P; Eisen B; Michele DE; Arad M; Binah O; Gottlieb E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
